FEMINIQUE CONTI (3 + 0,03) MG COM REV CT BL AL PLAS PVC/PVDC X 84
Apresentação · Câmara de Regulação do Mercado de Medicamentos (CMED), Secretaria Executiva exercida pela Agência Nacional de Vigilância Sanitária (ANVISA) · Brasil
-
Número de registro
1057300340043 -
GGREM
552923010155103 -
Código de barras
7896658040214
O que a fonte publica
- Detentor do registro
- ACHÉ LABORATÓRIOS FARMACÊUTICOS S.A
- Princípios ativos
- ETINILESTRADIOL;DROSPIRENONA
- Embalagem
- (3 + 0,03) MG COM REV CT BL AL PLAS PVC/PVDC X 84
- Regime de dispensação
- Tarja Vermelha
- Tipo de produto
- Similar
- Classe terapêutica
- G3A1 - HORMÔNIOS CONTRACEPTIVOS MONOFÁSICOS COM ESTROGÊNIOS <50MCG
- Prescrição
- Sob prescrição ou restrito
Nomes pelos quais este registro é encontrado
- FEMINIQUE CONTI (3 + 0,03) MG COM REV CT BL AL PLAS PVC/PVDC X 84
- FEMINIQUE CONTI
- ETINILESTRADIOL
- DROSPIRENONA
Dados completos da fonte
{
"name": "FEMINIQUE CONTI (3 + 0,03) MG COM REV CT BL AL PLAS PVC/PVDC X 84",
"holder": "ACHÉ LABORATÓRIOS FARMACÊUTICOS S.A",
"stripe": "Tarja Vermelha",
"barcodes": [
"7896658040214"
],
"confaz87": false,
"currency": "BRL",
"marketed": null,
"ggremCode": "552923010155103",
"useDomain": "unknown",
"capApplies": null,
"icmsExempt": false,
"holderTaxId": "60.659.463/0029-92",
"priceRegime": "Regulado",
"productName": "FEMINIQUE CONTI",
"productType": "Similar",
"hospitalOnly": false,
"presentation": "(3 + 0,03) MG COM REV CT BL AL PLAS PVC/PVDC X 84",
"sourceStatus": null,
"supplyRegime": "Tarja Vermelha",
"factoryPrices": {
"icms-0": "158.76",
"icms-12": "180.41",
"icms-17": "191.28",
"icms-18": "193.61",
"icms-19": "196.00",
"icms-20": "198.45",
"icms-21": "200.96",
"icms-22": "203.54",
"icms-23": "206.18",
"icms-17.5": "192.44",
"icms-19.5": "197.22",
"icms-20.5": "199.70",
"icms-22.5": "204.85",
"icms-12-alc": "178.24",
"icms-17-alc": "188.98",
"icms-18-alc": "191.29",
"icms-19-alc": "193.65",
"icms-20-alc": "196.07",
"icms-21-alc": "198.55",
"icms-22-alc": "201.10",
"icms-23-alc": "203.71",
"withoutTaxes": "156.85",
"icms-17.5-alc": "190.13",
"icms-19.5-alc": "194.85",
"icms-20.5-alc": "197.30",
"icms-22.5-alc": "202.39"
},
"pisCofinsList": "Positiva",
"substanceText": "ETINILESTRADIOL;DROSPIRENONA",
"targetSpecies": [],
"consumerPrices": {
"icms-0": "218.83",
"icms-12": "248.68",
"icms-17": "263.66",
"icms-18": "266.87",
"icms-19": "270.17",
"icms-20": "273.54",
"icms-21": "277.00",
"icms-22": "280.56",
"icms-23": "284.20",
"icms-17.5": "265.26",
"icms-19.5": "271.85",
"icms-20.5": "275.27",
"icms-22.5": "282.36",
"icms-12-alc": "246.41",
"icms-17-alc": "261.25",
"icms-18-alc": "264.45",
"icms-19-alc": "267.71",
"icms-20-alc": "271.06",
"icms-21-alc": "274.48",
"icms-22-alc": "278.01",
"icms-23-alc": "281.62",
"withoutTaxes": "216.84",
"icms-17.5-alc": "262.84",
"icms-19.5-alc": "269.37",
"icms-20.5-alc": "272.76",
"icms-22.5-alc": "279.79"
},
"invalidBarcodes": [],
"activeSubstances": [
"ETINILESTRADIOL",
"DROSPIRENONA"
],
"therapeuticClass": "G3A1 - HORMÔNIOS CONTRACEPTIVOS MONOFÁSICOS COM ESTROGÊNIOS <50MCG",
"commercialisation": {
"year": 2025,
"marketed": false
},
"priceAnalysisNote": null,
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "br.anvisa.cmed-prices"
},
"patientEligibility": "not-assessed",
"registrationNumber": "1057300340043",
"targetSpeciesStatus": "not-reported",
"administrativeStatus": "unknown",
"prescriptionCategory": "prescription-or-restricted",
"prescriptionRequired": true,
"therapeuticClassCode": "G3A1",
"commercialDestination": null,
"registrationNumberFlag": null
}
Leia este registro a partir do seu próprio software
O mesmo registro, com todos os campos e sua procedência, está a uma requisição de distância. A chave de API é gratuita e funciona imediatamente.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=br" \
--data-urlencode "sourceId=br.anvisa.cmed-prices" \
--data-urlencode "id=br:cmed:presentations:552923010155103"